Skip to content
★ Sign in to follow
SB
Total declarations
6
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (3 ops.)
€122k

Latest filing published 13 Nov 2019 for HAEMONETICS CORP, €36k.

Filing timeline

BuySale
Said Bolorforosh

Insider track record

Disclosed buys
0
Disclosed sells
3
Signal history

Said Bolorforosh: trading record in brief

Said Bolorforosh discloses dealings in Haemonetics Corp to SEC (Form 4). We count 6 filings; the first trade dates from 11 June 2018 and the latest from 11 November 2019.

Sales make up the whole of the open-market record (3 sales, €122k). Other entries cover 2 share grants and 1 option exercise. So far in 2019, the count stands at no purchases and 3 sales.

Most recently, on 13 November 2019, the filings show an open-market sale worth €36k in Haemonetics Corp. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Said Bolorforosh

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations6 total
  • ▼
    EVP, Chief Technology OfficerExecutivesHaemonetics Corp
    40,094 USD31SEC
    339 shares@ US$118.2718.9% of flowCommon StockSEC:0001127602-19-032647:0
  • ◇
    EVP, Chief Technology OfficerExecutivesHaemonetics Corp
    77,809 USD15SEC
    832 shares@ US$93.5236.5% of flowCommon StockSEC:0001127602-19-027768:0
  • ▼
    EVP, Chief Technology OfficerExecutivesHaemonetics Corp
    87,861 USD33SEC
    657 shares@ US$133.7341.2% of flowCommon StockSEC:0001127602-19-027768:1
  • ▼
    EVP, Chief Technology OfficerExecutivesHaemonetics Corp
    7,547 USD29SEC
    69 shares@ US$109.373.5% of flowCommon StockSEC:0001127602-19-021563:0
  • ◆
    EVP, Chief Technology OfficerExecutivesHaemonetics Corp
    0SEC
    1,275 sharesCommon StockSEC:0001127602-19-018739:0
  • ◆
    EVP, Chief Technology OfficerExecutivesHaemonetics Corp
    0SEC
    935 sharesCommon StockSEC:0001127602-18-020843:0

6 of 6 declarations